Blood-brain barrier: emerging trends on transport models and new-age strategies for therapeutics intervention against neurological disorders

被引:54
作者
Alajangi, Hema Kumari [1 ,2 ]
Kaur, Mandeep [1 ]
Sharma, Akanksha [1 ,2 ]
Rana, Sumedh [1 ]
Thakur, Shipali [1 ]
Chatterjee, Mary [3 ]
Singla, Neha [1 ]
Jaiswal, Pradeep Kumar [4 ]
Singh, Gurpal [2 ]
Barnwal, Ravi Pratap [1 ]
机构
[1] Panjab Univ, Dept Biophys, Chandigarh 160014, India
[2] Panjab Univ, Univ Inst Pharmaceut Sci, Chandigarh 160014, India
[3] Panjab Univ, Dept Biotechnol, UIET, Chandigarh 160014, India
[4] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA
关键词
Blood-brain barrier; BBB dysfunction; Drug delivery; Nanoparticles; Central nervous system; Neurological diseases; PEGYLATED LIPOSOMAL DOXORUBICIN; SOLID LIPID NANOPARTICLES; CENTRAL-NERVOUS-SYSTEM; PEG-PLA NANOPARTICLES; DRUG-DELIVERY; ALZHEIMERS-DISEASE; MULTIPLE-SCLEROSIS; IN-VITRO; AUTOIMMUNE DISORDERS; SIGNALING PATHWAYS;
D O I
10.1186/s13041-022-00937-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The integrity of the blood-brain barrier (BBB) is essential for normal central nervous system (CNS) functioning. Considering the significance of BBB in maintaining homeostasis and the neural environment, we aim to provide an overview of significant aspects of BBB. Worldwide, the treatment of neurological diseases caused by BBB disruption has been a major challenge. BBB also restricts entry of neuro-therapeutic drugs and hinders treatment modalities. Hence, currently nanotechnology-based approaches are being explored on large scale as alternatives to conventional methodologies. It is necessary to investigate the in-depth characteristic features of BBB to facilitate the discovery of novel drugs that can successfully cross the barrier and target the disease effectively. It is imperative to discover novel strategies to treat life-threatening CNS diseases in humans. Therefore, insights regarding building blocks of BBB, activation of immune response on breach of this barrier, and various autoimmune neurological disorders caused due to BBB dysfunction are discussed. Further, special emphasis is given on delineating BBB disruption leading to CNS disorders. Moreover, various mechanisms of transport pathways across BBB, several novel strategies, and alternative routes by which drugs can be properly delivered into CNS are also discussed.
引用
收藏
页数:28
相关论文
共 247 条
  • [1] Blood-brain barrier structure and function and the challenges for CNS drug delivery
    Abbott, N. Joan
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2013, 36 (03) : 437 - 449
  • [2] Structure and function of the blood-brain barrier
    Abbott, N. Joan
    Patabendige, Adjanie A. K.
    Dolman, Diana E. M.
    Yusof, Siti R.
    Begley, David J.
    [J]. NEUROBIOLOGY OF DISEASE, 2010, 37 (01) : 13 - 25
  • [3] Astrocyte-endothelial interactions at the blood-brain barrier
    Abbott, NJ
    Rönnbäck, L
    Hansson, E
    [J]. NATURE REVIEWS NEUROSCIENCE, 2006, 7 (01) : 41 - 53
  • [4] Dynamics of CNS barriers: Evolution, differentiation, and modulation
    Abbott, NJ
    [J]. CELLULAR AND MOLECULAR NEUROBIOLOGY, 2005, 25 (01) : 5 - 23
  • [5] Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs
    Agrawal, Mukta
    Saraf, Swarnlata
    Saraf, Shailendra
    Antimisiaris, Sophia G.
    Chougule, Mahavir Bhupal
    Shoyele, Sunday A.
    Alexander, Amit
    [J]. JOURNAL OF CONTROLLED RELEASE, 2018, 281 : 139 - 177
  • [6] Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region
    Agrawal, Mukta
    Saraf, Swarnlata
    Saraf, Shailendra
    Antimisiaris, Sophia G.
    Hamano, Nobuhito
    Li, Shyh-Dar
    Chougule, Mahavir
    Shoyele, Sunday A.
    Gupta, Umesh
    Ajazuddin
    Alexander, Amit
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2018, 15 (06) : 589 - 617
  • [7] The caudate nucleus undergoes dramatic and unique transcriptional changes in human prodromal Huntington's disease brain
    Agus, Filisia
    Crespo, Diego
    Myers, Richard H.
    Labadorf, Adam
    [J]. BMC MEDICAL GENOMICS, 2019, 12 (01)
  • [8] Polymersomes as viral capsid mimics
    Ahmed, Fariyal
    Photos, Peter J.
    Discher, Dennis E.
    [J]. DRUG DEVELOPMENT RESEARCH, 2006, 67 (01) : 4 - 14
  • [9] Liposome: classification, preparation, and applications
    Akbarzadeh, Abolfazl
    Rezaei-Sadabady, Rogaie
    Davaran, Soodabeh
    Joo, Sang Woo
    Zarghami, Nosratollah
    Hanifehpour, Younes
    Samiei, Mohammad
    Kouhi, Mohammad
    Nejati-Koshki, Kazem
    [J]. NANOSCALE RESEARCH LETTERS, 2013, 8
  • [10] Gene discovery in amyotrophic lateral sclerosis: implications for clinical management
    Al-Chalabi, Ammar
    van den Berg, Leonard H.
    Veldink, Jan
    [J]. NATURE REVIEWS NEUROLOGY, 2017, 13 (02) : 96 - 104